The researchers analyzed about 6,900 members of an Amish community in Lancaster County, Pennsylvania. Of these individuals, 6% carried the gene variant called B4GALT1, which lowered LDL cholesterol and fibrinogen levels. While 6% is exceedingly rare, the discovery of this gene may prove useful in development of heart disease treatments in the future. A lot of works still needs to be done, like the gene variant's mechanism of action, as well as if it has any negative effects. However, once these variables are determined, there may be hope of developing heart disease treatments using this information.